The TGA has identified all GLP-1 RA class products currently marketed in Australia are affected by the warning, including: semaglutide ( Ozempic, Wegovy ) liraglutide ( Saxenda ) dulaglutide ( Trulicity ) tirzepatide ( Mounjaro ) What should pharmacists do
The rush to reach maximum doses provides little benefit compared to tolerating lower doses comfortably for longer periods
Safety boundaries Clear warnings about inhalation, IV use, injections, and unsupported routes
This is a meaningful difference from standard ascorbic acid or cheap glutathione pills
Its structure promotes prolonged activity, allowing researchers to investigate mechanisms related to protein synthesis , muscle cell proliferation , and metabolic efficiency
Dynamic warm-ups increase blood flow, muscle temperature, and joint mobility, reducing injury risk and optimising workout efficiency